Lorazepam
- Product NDC
- 67296-1622
- Requested package NDC
- 67296-1622-1
- 11-digit product format
- 672961622
- Labeler code
- 67296
- Product ID
- 67296-1622_d61c4c9d-0d22-264d-e053-2a95a90a8c91
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lorazepam
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RedPharm Drug, Inc.
- Application
- ANDA078203
- Marketing category
- ANDA
- Marketing start
- 2018-01-01
- Marketing end
- 0000-00-00
- Substance
- LORAZEPAM
- Active strength
- 1 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 67296-1622 | 67296-1622-1 | I | Inactivated by FDA | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | 1332a3947898… | d4bfe170f9cd… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078203-001 | LORAZEPAM | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2007-07-30 | |
| A078203-002 | LORAZEPAM | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2007-07-30 | |
| A078203-003 | LORAZEPAM | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2007-07-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078203-001 | AB |
| A078203-002 | AB |
| A078203-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A078203-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2007-07-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A078203-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2007-07-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A078203-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2007-07-30 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A078203-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2007-07-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A078203-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2007-07-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A078203-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2007-07-30 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078203-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2007-07-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078203-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2007-07-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078203-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2007-07-30 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078203-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2007-07-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078203-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2007-07-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078203-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2007-07-30 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078203-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2007-07-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078203-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2007-07-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078203-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2007-07-30 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078203-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2007-07-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078203-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2007-07-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078203-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2007-07-30 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078203-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2007-07-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078203-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2007-07-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078203-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2007-07-30 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078203-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2007-07-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078203-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2007-07-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078203-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2007-07-30 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078203-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2007-07-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078203-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2007-07-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078203-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2007-07-30 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078203-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2007-07-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078203-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2007-07-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078203-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2007-07-30 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078203-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2007-07-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078203-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2007-07-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078203-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2007-07-30 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078203-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2007-07-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078203-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2007-07-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078203-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2007-07-30 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078203-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2007-07-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078203-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2007-07-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078203-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2007-07-30 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078203-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2007-07-30 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A078203-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A078203-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A078203-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A078203-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A078203-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A078203-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A078203-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A078203-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A078203-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078203-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078203-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078203-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A078203-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A078203-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A078203-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078203-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078203-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078203-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078203-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078203-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078203-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078203-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078203-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078203-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078203-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078203-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078203-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078203-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078203-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078203-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078203-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078203-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078203-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A078203-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A078203-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A078203-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078203-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078203-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078203-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078203-001 | AB | 1 | 301d65b070ca… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a759f740-8682-4896-9194-8b6c103c9aee | Product name | 3 | 20250716 |
| b7badb1c-6d3f-4f95-a4ca-ce69992e58a1 | Product name | 1 | 20220308 |
| 5d98a0ba-a64b-d9b2-e6ec-87edbb57a285 | Product name | 2 | 20180320 |
| ac8efea8-f412-295f-00ce-b095e5cbc115 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 67296-1622-1 | 2024-07-24 | C162847 | 48780-1 | 1030e365-6c5e-111a-e063-dadaa90a10e2 | Lorazepam 1mg |
| 67296-1622-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-6c5e-111a-e063-dadaa90a10e2 | Lorazepam 1mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67296-1622-1 | Lorazepam | 10 in 1 BOTTLE | TABLET | 10 | 12 | |
| 67296-1622-5 | Lorazepam | 5 in 1 BOTTLE | TABLET | 5 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 67296-1622 | LORAZEPAM TABLET [REDPHARM DRUG, INC.] | 12 | Legacy NDC, 1 package rows | 20240725_7b243fa7-6408-898b-e053-2991aa0a7acf.zip |
| 67296-1622 | LORAZEPAM TABLET [REDPHARM DRUG, INC.] | 2 | Legacy NDC, 1 package rows | 20240725_f4c3c2c5-52ce-a168-e053-2995a90affb4.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | be9f8bda-1cd9-40a6-a4da-b5961389fb5b | 2026-07-24 | Boxed warning, Warnings, Adverse reactions | 078203 ANDA078203 |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | d6364be4-056b-4ebe-83bc-3fc85e8f488c | 2026-07-09 | Boxed warning, Warnings, Adverse reactions | 078203 ANDA078203 |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | b707ecb2-644c-4323-ab0e-7bc5929cd560 | 2026-06-26 | Boxed warning, Warnings, Adverse reactions | 078203 ANDA078203 |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | 0cd02e52-ead5-4b2a-9708-c7c4be7b7995 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 078203 ANDA078203 |
| Lorazepam | LORAZEPAM | Coupler LLC | 5114810c-025f-6113-e063-6294a90af538 | 2026-05-05 | Boxed warning, Warnings, Adverse reactions | 078203 ANDA078203 |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | 1009c870-fd98-4e3b-81c8-4184036fb8c2 | 2026-01-26 | Boxed warning, Warnings, Adverse reactions | 078203 ANDA078203 |
| Lorazepam | LORAZEPAM | A-S Medication Solutions | 8361519b-be1a-4542-a782-d7cdfa153e86 | 2026-01-24 | Boxed warning, Warnings, Adverse reactions | 078203 ANDA078203 |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | a0a33933-f697-4d3b-ba99-8a995a4b6c6b | 2026-01-09 | Boxed warning, Warnings, Adverse reactions | 078203 ANDA078203 |
| LORAZEPAM | LORAZEPAM | DIRECT RX | 4832f02d-289c-2fe6-e054-00144ff8d46c | 2026-01-08 | Warnings, Adverse reactions | 078203 ANDA078203 |
| Lorazepam | LORAZEPAM | RedPharm Drug, Inc. | 891b2c10-942f-0e4d-e053-2995a90af028 | 2025-11-14 | Boxed warning, Warnings, Adverse reactions | 078203 ANDA078203 |
| Lorazepam | LORAZEPAM | PharmPak, Inc. | b6e4d2c7-10c0-4d77-be7b-caa3d3b86997 | 2025-11-10 | Boxed warning, Warnings, Adverse reactions | 078203 ANDA078203 |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 0681c8db-ff09-4258-a5e0-76a26b0ea0af | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | 078203 ANDA078203 |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 4a66b854-4dd6-3746-e054-00144ff8d46c | 2025-01-20 | Warnings, Adverse reactions | 078203 ANDA078203 |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 503834f9-fa2e-5e23-e054-00144ff88e88 | 2024-11-13 | Warnings, Adverse reactions | 078203 ANDA078203 |
| Lorazepam | LORAZEPAM | A-S Medication Solutions | be85b116-9f09-403a-8e0d-e77e344d3a9a | 2024-11-13 | Boxed warning, Warnings, Adverse reactions | 078203 ANDA078203 |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 4a66b854-4dc1-3746-e054-00144ff8d46c | 2024-10-08 | Warnings, Adverse reactions | 078203 ANDA078203 |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 4ab77192-8fe9-2965-e054-00144ff88e88 | 2024-07-19 | Warnings, Adverse reactions | 078203 ANDA078203 |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 50379c41-2676-590c-e054-00144ff8d46c | 2024-07-08 | Warnings, Adverse reactions | 078203 ANDA078203 |
| Lorazepam | LORAZEPAM | Bryant Ranch Prepack | aac672f9-0ba7-4852-b8a7-caac9e4b1e77 | 2024-05-15 | Boxed warning, Warnings, Adverse reactions | 078203 ANDA078203 |
| Lorazepam | LORAZEPAM | Proficient Rx LP | e9052b38-3c9f-4c84-9a0d-98bd99b9ddfd | 2024-05-01 | Boxed warning, Warnings, Adverse reactions | 078203 ANDA078203 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197901 | LORazepam 1 MG Oral Tablet | PSN | 7b243fa7-6408-898b-e053-2991aa0a7acf | 12 |
| 197901 | lorazepam 1 MG Oral Tablet | SCD | 7b243fa7-6408-898b-e053-2991aa0a7acf | 12 |
| 197901 | LORazepam 1 MG Oral Tablet | PSN | f4c3c2c5-52ce-a168-e053-2995a90affb4 | 2 |
| 197901 | lorazepam 1 MG Oral Tablet | SCD | f4c3c2c5-52ce-a168-e053-2995a90affb4 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 67296-1622-1 | 67296162201 | 10 TABLET in 1 BOTTLE (67296-1622-1) | 10 tablet | 2018-01-01 | 0000-00-00 | No | No | Current |